Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
2.780
-0.020 (-0.71%)
Aug 10, 2026, 11:32 AM EDT - Market open
Fate Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6.32 | 6.65 | 13.63 | 63.53 | 96.3 | 55.85 | |
Revenue Growth | -52.64% | -51.24% | -78.55% | -34.03% | 72.44% | 77.66% |
Gross Profit | 6.32 | 6.65 | 13.63 | 63.53 | 96.3 | 55.85 |
Selling, General & Admin | 42.34 | 46.52 | 74.17 | 81.45 | 84.23 | 57.32 |
Research & Development | 103.4 | 107.83 | 135 | 172.6 | 320.45 | 215.52 |
Other Operating Expenses | - | - | 14.74 | - | - | - |
Total Operating Expenses | 145.74 | 154.35 | 223.91 | 254.04 | 404.69 | 272.84 |
Operating Income | -139.42 | -147.7 | -210.28 | -190.51 | -308.39 | -216.99 |
Interest Income | 9.58 | 11.05 | 17.29 | 17.19 | 5.84 | 1.31 |
Other Non-Operating Income (Expense) | -0.07 | 0.34 | 6.73 | 12.4 | 20.82 | 3.53 |
Total Non-Operating Income (Expense) | 9.52 | 11.39 | 24.01 | 29.58 | 26.67 | 4.84 |
Pretax Income | -129.91 | -136.32 | -186.26 | -160.93 | -281.72 | -212.15 |
Net Income | -129.91 | -136.32 | -186.26 | -160.93 | -281.72 | -212.15 |
Net Income to Common | -129.91 | -136.32 | -186.26 | -160.93 | -281.72 | -212.15 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 119 | 119 | 114 | 98 | 97 | 95 |
Shares Outstanding (Diluted) | 119 | 119 | 114 | 98 | 97 | 95 |
Shares Change | 1.15% | 4.49% | 15.86% | 1.34% | 2.19% | 15.00% |
EPS (Basic) | -1.09 | -1.15 | -1.64 | -1.64 | -2.91 | -2.24 |
EPS (Diluted) | -1.09 | -1.15 | -1.64 | -1.64 | -2.91 | -2.24 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -108.09 | -112.04 | -123.6 | -138.42 | -283.77 | -213.57 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.91 | -0.94 | -1.09 | -1.41 | -2.93 | -2.25 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -2207.47% | -2222.45% | -1542.63% | -299.86% | -320.24% | -388.56% |
Profit Margin | -2056.79% | -2051.08% | -1366.46% | -253.30% | -292.55% | -379.89% |
FCF Margin | -1711.42% | -1685.78% | -906.79% | -217.87% | -294.68% | -382.43% |
EBITDA | -126.94 | -134.8 | -191.31 | -172.23 | -294.63 | -211.14 |
EBITDA Margin | -2009.78% | -2028.33% | -1403.52% | -271.09% | -305.95% | -378.08% |
EBIT | -139.42 | -147.7 | -210.28 | -190.51 | -308.39 | -216.99 |
EBIT Margin | -2207.47% | -2222.45% | -1542.63% | -299.86% | -320.24% | -388.56% |